O

OmniAb Inc
NASDAQ:OABI

Watchlist Manager
OmniAb Inc
NASDAQ:OABI
Watchlist
Price: 3.92 USD 1.82% Market Closed
Market Cap: 463.2m USD
Have any thoughts about
OmniAb Inc?
Write Note

OmniAb Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

OmniAb Inc
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
O
OmniAb Inc
NASDAQ:OABI
Cash from Investing Activities
-$18.4m
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Cash from Investing Activities
-$6.2B
CAGR 3-Years
-17%
CAGR 5-Years
-27%
CAGR 10-Years
6%
Danaher Corp
NYSE:DHR
Cash from Investing Activities
-$7.3B
CAGR 3-Years
17%
CAGR 5-Years
-42%
CAGR 10-Years
-22%
Mettler-Toledo International Inc
NYSE:MTD
Cash from Investing Activities
-$103.9m
CAGR 3-Years
28%
CAGR 5-Years
3%
CAGR 10-Years
-1%
Agilent Technologies Inc
NYSE:A
Cash from Investing Activities
-$344m
CAGR 3-Years
22%
CAGR 5-Years
8%
CAGR 10-Years
-4%
IQVIA Holdings Inc
NYSE:IQV
Cash from Investing Activities
-$1.3B
CAGR 3-Years
7%
CAGR 5-Years
-4%
CAGR 10-Years
-24%
No Stocks Found

OmniAb Inc
Glance View

Market Cap
471.3m USD
Industry
Life Sciences Tools & Services

OmniAb, Inc. operates as a drug discovery company. The company is headquartered in Emeryville, California and currently employs 93 full-time employees. The company went IPO on 2020-10-09. The OmniAb platform is the biological intelligence (BI) of transgenic animals, including OmniRat, OmniChicken, and OmniMouse, which have been genetically modified to generate antibodies with human sequences to facilitate the development of human therapeutic candidates. Its OmniFlic (transgenic rat) and OmniClic (transgenic chicken) address industry needs for bispecific antibody applications through a common light chain approach and OmniTaur features structural attributes of cow antibodies for complex targets. The firm's OmniChicken and OmniClic offer affinity-matured antibodies in an evolutionarily distant chicken host environment, which can deliver a diverse repertoire of antibody panels to conserved therapeutic targets.

OABI Intrinsic Value
4.35 USD
Undervaluation 10%
Intrinsic Value
Price
O

See Also

What is OmniAb Inc's Cash from Investing Activities?
Cash from Investing Activities
-18.4m USD

Based on the financial report for Dec 31, 2023, OmniAb Inc's Cash from Investing Activities amounts to -18.4m USD.

What is OmniAb Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
12%

Over the last year, the Cash from Investing Activities growth was 75%. The average annual Cash from Investing Activities growth rates for OmniAb Inc have been 12% over the past three years .

Back to Top